Abstract
Background
Cancer remains a major global health burden and existing therapeutic approaches face substantial challenges such as drug resistance, poor selectivity, heterogeneity, and the complex tumor microenvironment. Nanotechnology has evolved into a promising tool with huge potential for application in the field of medicine. Recently, inorganic nanoparticles (INPs) have been widely explored for cancer therapy because of their distinct tunable physicochemical properties, biocompatibility, and versatile preparation methods. In addition, surface functionalization of INPs has further improved therapeutics efficacy by modulating their features, such as poor aqueous solubility, in vivo stability, potential toxicity, enhanced cancer targeting, and reduced binding to healthy cells.
Area covered
In this review, we briefly highlight a few of the most commonly used INPs in cancer therapy, along with their basic features and fabrication methods. Strategies, commonly employed materials and reasons for surface functionalization of INPs have also been described. Furthermore, the latest drug delivery and therapeutic applications of surface-functionalized INPs in various cancers were extensively reviewed. This review concludes with a future outlook and a few limitations of surface-functionalized INPs that hinder their clinical application.
Expert opinion
The presented data undoubtedly prove the potential of surface-functionalized INPs to improve therapeutic efficacy, cellular uptake, and tumor growth inhibition of anti-tumor drugs, thereby minimizing their limitations in cancer therapy. However, functionalized INPs have a negligible presence in the market for cancer therapy despite their promising potential. Appropriate designing and clinically relevant testing may facilitate their clinical translation into safe and effective cancer therapy in the near future.
Similar content being viewed by others
References
Abedin MR, Umapathi S, Mahendrakar H, Laemthong T, Coleman H, Muchangi D, Santra S, Nath M, Barua S (2018) Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications. J Nanobiotechnol 16:80
Afsana S, Prashant K (2021) An insight into aptamer engineered dendrimer for cancer therapy. Eur Polym J 159:110746
Agwa MM, Sabra S (2021) Lactoferrin coated or conjugated nanomaterials as an active targeting approach in nanomedicine. Int J Biol Macromol 167:1527–1543
Aisida SO, Akpa PA, Ahmad I, Zhao T-K, Maaza M, Ezema FI (2020) Bio-inspired encapsulation and functionalization of iron oxide nanoparticles for biomedical applications. Eur Polym J 122:109371
Al Faraj A, Shaik AS, Ratemi E, Halwani R (2016) Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model. J Control Release 225:240–251
Alalaiwe A, Roberts G, Carpinone P, Munson J, Roberts S (2017) Influence of PEG coating on the oral bioavailability of gold nanoparticles in rats. Drug Deliv 24:591–598
Alalaiwe A, Carpinone P, Alshahrani S, Alsulays B, Ansari M, Anwer M, Alshehri S, Alshetaili A (2019) Influence of chitosan coating on the oral bioavailability of gold nanoparticles in rats. Saudi Pharm J 27:171–175
Ali A, Zafar H, Zia M, Ul Haq I, Phull AR, Ali JS, Hussain A (2016) Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl 9:49–67
AlleBr MG, Kim TH, Park SH, Lee SH, Kim JC (2020) Doxorubicin-carboxymethyl xanthan gum capped gold nanoparticles: Microwave synthesis, characterization, and anti-cancer activity. Carbohydr Polym 229:115511
Amaldoss MJN, Yang J-L, Koshy P, Unnikrishnan A, Sorrell CC (2022) Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies. Drug Discov Today 27:103386
Amin MU, Ali S, Ali MY, Tariq I, Nasrullah U, Pinnapreddy SR, Wölk C, Bakowsky U, Brüßler J (2021) Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy. Eur J Pharm Biopharm 165:31–40
Amir M, Andrew MM, Michael BC (2012) Zinc oxide particles: synthesis, properties and applications. Chem Eng J 185–186:1–22
Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15–23
Aryal S, Grailer JJ, Pilla S, Steeber DA, Gong S (2009) Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers. J Mater Chem 19:7879–7884
Asadishad B, Vossoughi M, Alemzadeh I (2010) Folate-receptor-targeted delivery of doxorubicin using polyethylene glycol-functionalized gold nanoparticles. Ind Eng Chem Res 49:1958–1963
Atlı Şekeroğlu Z, Şekeroğlu V, Aydın B, Kontaş Yedier S (2023) Cerium oxide nanoparticles exert antitumor effects and enhance paclitaxel toxicity and activity against breast cancer cells. J Biomed Mater Res B 111:579–589
Babaei M, Abnous K, Taghdisi SM, Taghavi S, Saljooghi SA, Ramezani M, Alibolandi M (2020) Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Eur J Pharm Biopharm 156:84–96
Bailly A-L, Correard F, Popov A, Tselikov G, Chaspoul F, Appay R, Al-Kattan A, Kabashin AV, Braguer D, Esteve M-A (2019) In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles. Sci Rep 9:12890
Bandyopadhyay A, Roy B, Shaw P, Mondal P, Mondal MK, Chowdhury P, Bhattacharya S, Chattopadhyay A (2020) Cytotoxic effect of green synthesized silver nanoparticles in MCF7 and MDA-MB-231 human breast cancer cells in vitro. Nucleus 63:191–202
Banoee M, Seif S, Nazari ZE, Jafari-Fesharaki P, Shahverdi HR, Moballegh A, Moghaddam KM, Shahverdi AR (2010) ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli. J Biomed Mater Res B 93:557–561
Banu H, Sethi DK, Edgar A, Sheriff A, Rayees N, Renuka N, Faheem SM, Premkumar K, Vasanthakumar G (2015) Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines. J Photochem Photobiol B 149:116–128
Bayda S, Hadla M, Palazzolo S, Riello P, Corona G, Toffoli G, Rizzolio F (2018) Inorganic nanoparticles for cancer therapy: a transition from lab to clinic. Curr Med Chem 25:4269–4303
Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P (2011) Inorganic nanoparticles in cancer therapy. Pharm Res 28:237–259
Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674–690
Bianco A (2004) Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin Drug Deliv 1:57–65
Cai X, Luo Y, Zhang W, Du D, Lin Y (2016) pH-sensitive ZnO quantum dots-doxorubicin nanoparticles for lung cancer targeted drug delivery. ACS Appl Mater Interfaces 8:22442–22450
Cháfer-Pericás C, Maquieira A, Puchades R (2012) Functionalized inorganic nanoparticles used as labels in solid-phase immunoassays. Trends Analyt Chem 31:144–156
Chakraborti S, Chakraborty S, Saha S, Manna A, Banerjee S, Adhikary A, Sarwar S, Hazra TK, Das T, Chakrabarti P (2017) PEG-functionalized zinc oxide nanoparticles induce apoptosis in breast cancer cells through reactive oxygen species-dependent impairment of DNA damage repair enzyme NEIL2. Free Radic Biol Med 103:35–47
Chen W-H, Luo G-F, Qiu W-X, Lei Q, Hong S, Wang S-B, Zheng D-W, Zhu C-H, Zeng X, Feng J, Cheng S-X, Zhang X-Z (2016a) Programmed nanococktail for intracellular cascade reaction regulating self-synergistic tumor targeting therapy. Small 12:733–744
Chen Y, Xu Z, Zhu D, Tao X, Gao Y, Zhu H, Mao Z, Ling J (2016b) Gold nanoparticles coated with polysarcosine brushes to enhance their colloidal stability and circulation time in vivo. J Colloid Interface Sci 483:201–210
Chen H, Luo L, Fan S, Xiong Y, Ling Y, Peng S (2021) Zinc oxide nanoparticles synthesized from Aspergillus terreus induces oxidative stress-mediated apoptosis through modulating apoptotic proteins in human cervical cancer HeLa cells. J Pharm Pharmacol 73:221–232
Cirillo G, Vittorio O, Kunhardt D, Valli E, Voli F, Farfalla A, Curcio M, Spizzirri UG, Hampel S (2019) Combining carbon nanotubes and chitosan for the vectorization of methotrexate to lung cancer cells. Materials 12:2889
Conde J, Tian F, Hernández Y, Bao C, Cui D, Janssen K-P, Ibarra MR, Baptista PV, Stoeger T, De La Fuente JM (2013) In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models. Biomaterials 34:7744–7753
Dadfar SM, Roemhild K, Drude NI, Von Stillfried S, Knüchel R, Kiessling F, Lammers T (2019) Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev 138:302–325
Darweesh RS, Ayoub NM, Nazzal S (2019) Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications. Int J Nanomed 14:7643–7663
Das A, Soehnlen E, Woods S, Hegde R, Henry A, Gericke A, Basu S (2011) VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy. J Nanopart Res 13:6283–6290
Das B, Tripathy S, Adhikary J, Chattopadhyay S, Mandal D, Dash SK, Das S, Dey A, Dey SK, Das D, Roy S (2017) Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study. J Biol Inorg Chem 22:893–918
Datir SR, Das M, Singh RP, Jain S (2012) Hyaluronate tethered, “smart” multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjug Chem 23:2201–2213
De Matteis V, Cascione M, Toma CC, Leporatti S (2018) Silver nanoparticles: synthetic routes, in vitro toxicity and theranostic applications for cancer disease. Nanomaterials 8:319
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:20503121211034370
Dewi FRP, Shoukat N, Alifiyah NI, Wahyuningsih SPA, Rosyidah A, Prenggono MD, Hartono H (2022) Increasing the effect of annonacin using nanodiamonds to inhibit breast cancer cells growth in rats (Rattus norvegicus)-induced breast cancer. Heliyon 8:e11418
Dey AD, Bigham A, Esmaeili Y, Ashrafizadeh M, Moghaddam FD, Tan SC, Yousefiasl S, Sharma S, Maleki A, Rabiee N, Kumar AP, Thakur VK, Orive G, Sharifi E, Kumar A, Makvandi P (2022) Dendrimers as nanoscale vectors: unlocking the bars of cancer therapy. Semin Cancer Biol 86:396–419
Dhall A, Self W (2018) Cerium oxide nanoparticles: a brief review of their synthesis methods and biomedical applications. Antioxidants 7:97
Dhamecha D, Jalalpure S, Jadhav K, Jagwani S, Chavan R (2016) Doxorubicin loaded gold nanoparticles: implication of passive targeting on anticancer efficacy. Pharmacol Res 113:547–556
Di Martino A, Guselnikova OA, Trusova ME, Postnikov PS, Sedlarik V (2017) Organic-inorganic hybrid nanoparticles controlled delivery system for anticancer drugs. Int J Pharm 526:380–390
Dumontel B, Canta M, Engelke H, Chiodoni A, Racca L, Ancona A, Limongi T, Canavese G, Cauda V (2017) Enhanced biostability and cellular uptake of zinc oxide nanocrystals shielded with a phospholipid bilayer. J Mater Chem B 5:8799–8813
El-Sonbaty SM (2013) Fungus-mediated synthesis of silver nanoparticles and evaluation of antitumor activity. Cancer Nanotechnol 4:73–79
Erathodiyil N, Ying JY (2011) Functionalization of inorganic nanoparticles for bioimaging applications. Acc Chem Res 44:925–935
Feliu N, Docter D, Heine M, Del Pino P, Ashraf S, Kolosnjaj-Tabi J, Macchiarini P, Nielsen P, Alloyeau D, Gazeau F, Stauber RH, Parak WJ (2016) In vivo degeneration and the fate of inorganic nanoparticles. Chem Soc Rev 45:2440–2457
Fitzgerald G, Low D, Morgan L, Hilt C, Benford M, Akers C, Hornback S, Hilt JZ, Scott D (2023) Controlled release of DNA binding anticancer drugs from gold nanoparticles with near-infrared radiation. J Pharm Sci 112:1064–1071
Foldbjerg R, Dang DA, Autrup H (2011) Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–750
Gao Y, Chen K, Ma JL, Gao F (2014) Cerium oxide nanoparticles in cancer. Onco Targets Ther 7:835–840
Gao Y, Zhong S, Xu L, He S, Dou Y, Zhao S, Chen P, Cui X (2019) Mesoporous silica nanoparticles capped with graphene quantum dots as multifunctional drug carriers for photo-thermal and redox-responsive release. Microporous Mesoporous Mater 278:130–137
Gao Q, Zhang J, Gao J, Zhang Z, Zhu H, Wang D (2021) Gold nanoparticles in cancer theranostics. Front Bioeng Biotechnol 9:647905
Ghosh R, Singh LC, Shohet JM, Gunaratne PH (2013) A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials 34:807–816
Goddard ZR, Marín MJ, Russell DA, Searcey M (2020) Active targeting of gold nanoparticles as cancer therapeutics. Chem Soc Rev 49:8774–8789
Goel R, Shah N, Visaria R, Paciotti GF, Bischof JC (2009) Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine 4:401–410
Gomathi AC, Xavier Rajarathinam SR, Mohammed Sadiq A, Rajeshkumar S (2020) Anticancer activity of silver nanoparticles synthesized using aqueous fruit shell extract of Tamarindus indica on MCF-7 human breast cancer cell line. J Drug Deliv Sci Technol 55:101376
Gupta U, Saren BN, Khaparkhuntikar K, Madan J, Singh PK (2022) Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer. J Control Release 348:1089–1115
He Y, Du Z, Ma S, Liu Y, Li D, Huang H, Jiang S, Cheng S, Wu W, Zhang K, Zheng X (2016) Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivo. Int J Nanomed 11:1879–1887
Hemben A, Chianella I, Leighton GJT (2021) Surface engineered iron oxide nanoparticles generated by inert gas condensation for biomedical applications. Bioengineering 8:38
Heo DN, Yang DH, Moon H-J, Lee JB, Bae MS, Lee SC, Lee WJ, Sun I-C, Kwon IK (2012) Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 33:856–866
Herizchi R, Abbasi E, Milani M, Akbarzadeh A (2016) Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol 44:596–602
Hoang Thi TT, Cao VD, Nguyen TNQ, Hoang DT, Ngo VC, Nguyen DH (2019) Functionalized mesoporous silica nanoparticles and biomedical applications. Mater Sci Eng C 99:631–656
Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH (2020) Protein-based nanoparticles as drug delivery systems. Pharmaceutics 12:604
Hu JJ, Xiao D, Zhang XZ (2016) Advances in peptide functionalization on mesoporous silica nanoparticles for controlled drug release. Small 12:3344–3359
Huang HC, Barua S, Sharma G, Dey SK, Rege K (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155:344–357
Huang X, Qi X, Boey F, Zhang H (2012) Graphene-based composites. Chem Soc Rev 41:666–686
Iannazzo D, Pistone A, Salamò M, Galvagno S, Romeo R, Giofré SV, Branca C, Visalli G, Di Pietro A (2017) Graphene quantum dots for cancer targeted drug delivery. Int J Pharm 518:185–192
Iravani S, Korbekandi H, Mirmohammadi SV, Zolfaghari B (2014) Synthesis of silver nanoparticles: chemical, physical and biological methods. Res Pharm Sci 9:385–406
Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti BS, Saboury AA (2019) Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed Pharmacother 109:1100–1111
Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V (2005) Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2:194–205
Jiang J, Pi J, Cai J (2018) The advancing of zinc oxide nanoparticles for biomedical applications. Bioinorg Chem Appl 2018:1062562
Jiang L, Santiago I, Foord J (2020a) High-yield electrochemical synthesis of silver nanoparticles by enzyme-modified boron-doped diamond electrodes. Langmuir 36:6089–6094
Jiang W, Chen J, Gong C, Wang Y, Gao Y, Yuan Y (2020b) Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy. J Nanobiotechnol 18:50
Jorge G-B, José L-D-L, Miguel M (2011) Silver nanoparticles: synthesis through chemical methods in solution and biomedical applications. Open Chem 9:7–19
Kang J-W, Cho H-J, Lee HJ, Jin H-E, Maeng H-J (2019) Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream. Int J Biol Macromol 125:61–71
Kankala RK, Han YH, Na J, Lee CH, Sun Z, Wang SB, Kimura T, Ok YS, Yamauchi Y, Chen AZ, Wu KC (2020) Nanoarchitectured structure and surface biofunctionality of mesoporous silica nanoparticles. Adv Mater 32:e1907035
Kaushik N, Borkar SB, Nandanwar SK, Panda PK, Choi EH, Kaushik NK (2022) Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms. J Nanobiotechnol 20:152
Khan Z, Bisen PS (2013) Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer. Biochim Biophys Acta Rev Cancer 1836:123–145
Khan K, Javed S (2018) Functionalization of inorganic nanoparticles to augment antimicrobial efficiency: a critical analysis. Curr Pharm Biotechnol 19:523–536
Khan MA, Singh D, Ahmad A, Siddique HR (2021) Revisiting inorganic nanoparticles as promising therapeutic agents: a paradigm shift in oncological theranostics. Eur J Pharm Sci 164:105892
Khodashenas B, Ardjmand M, Rad AS, Esfahani MR (2021) Gelatin-coated gold nanoparticles as an effective pH-sensitive methotrexate drug delivery system for breast cancer treatment. Mater Today Chem 20:100474
Kossatz S, Grandke J, Couleaud P, Latorre A, Aires A, Crosbie-Staunton K, Ludwig R, Dähring H, Ettelt V, Lazaro-Carrillo A, Calero M, Sader M, Courty J, Volkov Y, Prina-Mello A, Villanueva A, Somoza Á, Cortajarena AL, Miranda R, Hilger I (2015) Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res 17:66
Kostiv U, Patsula V, Šlouf M, Pongrac IM, Škokić S, Radmilović MD, Pavičić I, Vrček IV, Gajović S, Horák D (2017) Physico-chemical characteristics, biocompatibility, and MRI applicability of novel monodisperse PEG-modified magnetic Fe3O4 & SiO2 core–shell nanoparticles. RSC Adv 7:8786–8797
Kruse AM, Meenach SA, Anderson KW, Hilt JZ (2014) Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications. Acta Biomater 10:2622–2629
Kubota T, Kuroda S, Kanaya N, Morihiro T, Aoyama K, Kakiuchi Y, Kikuchi S, Nishizaki M, Kagawa S, Tazawa H, Fujiwara T (2018) HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer. Nanomedicine 14:1919–1929
Kumar A, Ma H, Zhang X, Huang K, Jin S, Liu J, Wei T, Cao W, Zou G, Liang X-J (2012) Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials 33:1180–1189
Kundu M, Sadhukhan P, Ghosh N, Chatterjee S, Manna P, Das J, Sil PC (2019) pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy. J Adv Res 18:161–172
Lee J, Chatterjee DK, Lee MH, Krishnan S (2014) Gold nanoparticles in breast cancer treatment: promise and potential pitfalls. Cancer Lett 347:46–53
Li J, Zhu Y, Li W, Zhang X, Peng Y, Huang Q (2010) Nanodiamonds as intracellular transporters of chemotherapeutic drug. Biomaterials 31:8410–8418
Li Y, Guo M, Lin Z, Zhao M, Xiao M, Wang C, Xu T, Chen T, Zhu B (2016) Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis. Int J Nanomed 11:6693–6702
Li Y, Duo Y, Bi J, Zeng X, Mei L, Bao S, He L, Shan A, Zhang Y, Yu X (2018a) Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy. Int J Nanomed 13:1241–1256
Li Y, Duo Y, Zhai P, He L, Zhong K, Zhang Y, Huang K, Luo J, Zhang H, Yu X (2018b) Dual targeting delivery of miR-328 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy. Nanomedicine 13:1753–1772
Li Z, Zhang Y, Zhang K, Wu Z, Feng N (2018c) Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA. Artif Cells Nanomed Biotechnol 46:578–587
Li W, Cao Z, Liu R, Liu L, Li H, Li X, Chen Y, Lu C, Liu Y (2019a) AuNPs as an important inorganic nanoparticle applied in drug carrier systems. Artif Cells Nanomed Biotechnol 47:4222–4233
Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z, Du Y, Li Q, Lou Y, Qiu Y, You J (2019b) Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun 10:3349
Li X, Jian M, Sun Y, Zhu Q, Wang Z (2021) The peptide functionalized inorganic nanoparticles for cancer-related bioanalytical and biomedical applications. Molecules 26:3228
Li QR, Xu HZ, Xiao RC, Liu Y, Tang JM, Li J, Yu TT, Liu B, Li LG, Wang MF, Han N, Xu YH, Wang C, Komatsu N, Zhao L, Peng XC, Li TF, Chen X (2022a) Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery. Drug Deliv 29:937–949
Li Y, Su Y, Pan H, Deng W, Wang J, Liu D, Pan W (2022b) Nanodiamond-based multifunctional platform for oral chemo-photothermal combinational therapy of orthotopic colon cancer. Pharmacol Res 176:106080
Liao W-S, Ho Y, Lin Y-W, Naveen Raj E, Liu K-K, Chen C, Zhou X-Z, Lu K-P, Chao J-I (2019) Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite. Acta Biomater 86:395–405
Lin KS, Chowdhury S (2010) Synthesis, characterization, and application of 1-D cerium oxide nanomaterials: a review. Int J Mol Sci 11:3226–3251
Liszbinski RB, Romagnoli GG, Gorgulho CM, Basso CR, Pedrosa VA, Kaneno R (2020) Anti-EGFR-coated gold nanoparticles in vitro carry 5-fluorouracil to colorectal cancer cells. Materials 13:375
Liu X, Tao H, Yang K, Zhang S, Lee S-T, Liu Z (2011) Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 32:144–151
Liu J, Cui L, Losic D (2013) Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 9:9243–9257
Liu J, Dong J, Zhang T, Peng Q (2018a) Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy. J Control Release 286:64–73
Liu J, Zhang D, Lian S, Zheng J, Li B, Li T, Jia L (2018b) Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs. Int J Nanomed 13:7457–7472
Liu CM, Chen GB, Chen HH, Zhang JB, Li HZ, Sheng MX, Weng WB, Guo SM (2019) Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Colloids Surf B 175:477–486
Liu D, Su Y, Chen J, Pan H, Pan W (2023) Folic acid-chitosan oligosaccharide conjugates decorated nanodiamond as potential carriers for the oral delivery of doxorubicin. AAPS PharmSciTech 24:86
Lu J, Liong M, Zink JI, Tamanoi F (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3:1341–1346
Lu J, Liong M, Li Z, Zink JI, Tamanoi F (2010) Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6:1794–1805
Lu H, Wan L, Li X, Zhang M, Shakoor A, Li W, Zhang X (2022) Combined synthesis of cerium oxide particles for effective anti-bacterial and anti-cancer nanotherapeutics. Int J Nanomed 17:5733–5746
Luchini A, Vitiello G (2019) Understanding the Nano-bio interfaces: lipid-coatings for inorganic nanoparticles as promising strategy for biomedical applications. Front Chem 7:343
Malugin A, Ghandehari H (2010) Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol 30:212–217
Meena J, Gupta A, Ahuja R, Singh M, Bhaskar S, Panda AK (2020) Inorganic nanoparticles for natural product delivery: a review. Environ Chem Lett 18:2107–2118
Meena D, Vimala K, Kannan S (2022) Combined delivery of DOX and Kaempferol using PEGylated gold nanoparticles to target colon cancer. J Clust Sci 33:173–187
Mehra NK, Jain NK (2015) Cancer targeting propensity of folate conjugated surface engineered multi-walled carbon nanotubes. Colloids Surf B 132:17–26
Mena S, Ortega A, Estrela JM (2009) Oxidative stress in environmental-induced carcinogenesis. Mutat Res 674:36–44
Mo J, He L, Ma B, Chen T (2016) Tailoring particle size of mesoporous silica nanosystem to antagonize glioblastoma and overcome blood-brain barrier. ACS Appl Mater Interfaces 8:6811–6825
Montalvo-Quiros S, Aragoneses-Cazorla G, Garcia-Alcalde L, Vallet-Regí M, González B, Luque-Garcia JL (2019) Cancer cell targeting and therapeutic delivery of silver nanoparticles by mesoporous silica nanocarriers: insights into the action mechanisms using quantitative proteomics. Nanoscale 11:4531–4545
Moon HK, Lee SH, Choi HC (2009) In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 3:3707–3713
Morais RP, Novais GB, Sangenito LS, Santos ALS, Priefer R, Morsink M, Mendonça MC, Souto EB, Severino P, Cardoso JC (2020) Naringenin-functionalized multi-walled carbon nanotubes: a potential approach for site-specific remote-controlled anticancer delivery for the treatment of lung cancer cells. Int J Mol Sci 21:4557
Muhammad Z, Raza A, Ghafoor S, Naeem A, Naz SS, Riaz S, Ahmed W, Rana NF (2016) PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility. Eur J Pharm Sci 91:251–255
Mussa Farkhani S, Asoudeh Fard A, Zakeri-Milani P, Shahbazi Mojarrad J, Valizadeh H (2017) Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides. Artif Cells Nanomed Biotechnol 45:1029–1035
Nadeem M, Khan R, Shah N, Bangash IR, Abbasi BH, Hano C, Liu C, Ullah S, Hashmi SS, Nadhman A, Celli J (2021) A review of microbial mediated iron nanoparticles (IONPs) and its biomedical applications. Nanomaterials 12:130
Naghizadeh A, Mohammadi-Aghdam S, Mortazavi-Derazkola S (2020) Novel CoFe(2)O(4)@ZnO-CeO(2) ternary nanocomposite: sonochemical green synthesis using Crataegus microphylla extract, characterization and their application in catalytic and antibacterial activities. Bioorg Chem 103:104194
Nakkala JR, Mata R, Raja K, Khub Chandra V, Sadras SR (2018) Green synthesized silver nanoparticles: catalytic dye degradation, in vitro anticancer activity and in vivo toxicity in rats. Mater Sci Eng C 91:372–381
Nam J, Won N, Bang J, Jin H, Park J, Jung S, Jung S, Park Y, Kim S (2013) Surface engineering of inorganic nanoparticles for imaging and therapy. Adv Drug Deliv Rev 65:622–648
Narayan R, Nayak UY, Raichur AM, Garg S (2018) Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics 10:118
Nasrollahi F, Varshosaz J, Khodadadi AA, Lim S, Jahanian-Najafabadi A (2016) Targeted delivery of docetaxel by use of Transferrin/Poly(allylamine hydrochloride)-functionalized graphene oxide nanocarrier. ACS Appl Mater Interfaces 8:13282–13293
Navada MK, Karnikkar NG, D’souza JN, Kouser S, Aroor G, Kudva J, Jayappa MD (2023) Biosynthesis of phyto functionalized cerium oxide nanoparticles mediated from Scoparia dulsis L. for appraisal of anti-cancer potential against adenocarcinomic lung cancer cells and paracetamol sensing potentiality. Environ Sci Pollut Res Int 30:18901–18920
Nejati K, Dadashpour M, Gharibi T, Mellatyar H, Akbarzadeh A (2022) Biomedical applications of functionalized gold nanoparticles: a review. J Clust Sci 33:1–16
Nirmala MJ, Kizhuveetil U, Johnson A, Balaji G, Nagarajan R, Muthuvijayan V (2023) Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv 13:8606–8629
Norouzi M, Yathindranath V, Thliveris JA, Kopec BM, Siahaan TJ, Miller DW (2020) Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci Rep 10:11292
Nourmohammadi E, Khoshdel-Sarkarizi H, Nedaeinia R, Sadeghnia HR, Hasanzadeh L, Darroudi M, Kazemi Oskuee R (2019) Evaluation of anticancer effects of cerium oxide nanoparticles on mouse fibrosarcoma cell line. J Cell Physiol 234:4987–4996
Nourmohammadi E, Khoshdel-Sarkarizi H, Nedaeinia R, Darroudi M, KazemiOskuee R (2020) Cerium oxide nanoparticles: a promising tool for the treatment of fibrosarcoma in-vivo. Mater Sci Eng C 109:110533
Ong C, Lim JZ, Ng CT, Li JJ, Yung LY, Bay BH (2013) Silver nanoparticles in cancer: therapeutic efficacy and toxicity. Curr Med Chem 20:772–781
Pandey PC, Shukla S, Pandey G, Narayan RJ (2021) Nanostructured diamond for biomedical applications. Nanotechnology 32:132001
Pandita D, Munjal A, Poonia N, Awasthi R, Kalonia H, Lather V (2021) Albumin-coated mesoporous silica nanoparticles of docetaxel: preparation, characterization, and pharmacokinetic evaluation. Assay Drug Dev Technol 19:226–236
Park T, Lee S, Amatya R, Cheong H, Moon C, Kwak HD, Min KA, Shin MC (2020) ICG-loaded PEGylated BSA-silver nanoparticles for effective photothermal cancer therapy. Int J Nanomed 15:5459–5471
Passeri D, Rinaldi F, Ingallina C, Carafa M, Rossi M, Terranova ML, Marianecci C (2015) Biomedical applications of nanodiamonds: an overview. J Nanosci Nanotechnol 15:972–988
Patra CR, Bhattacharya R, Wang E, Katarya A, Lau JS, Dutta S, Muders M, Wang S, Buhrow SA, Safgren SL, Yaszemski MJ, Reid JM, Ames MM, Mukherjee P, Mukhopadhyay D (2008) Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res 68:1970–1978
Peikang B, Shengliang H, Taiping Z, Jing S, Shirui C (2010) Effect of laser pulse parameters on the size and fluorescence of nanodiamonds formed upon pulsed-laser irradiation. Mater Res Bull 45:826–829
Peng Y, Song C, Yang C, Guo Q, Yao M (2017) Low molecular weight chitosan-coated silver nanoparticles are effective for the treatment of MRSA-infected wounds. Int J Nanomed 12:295–304
Pešić M, Podolski-Renić A, Stojković S, Matović B, Zmejkoski D, Kojić V, Bogdanović G, Pavićević A, Mojović M, Savić A, Milenković I, Kalauzi A, Radotić K (2015) Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity. Chem Biol Interact 232:85–93
Piao J-G, Wang L, Gao F, You Y-Z, Xiong Y, Yang L (2014) Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. ACS Nano 8:10414–10425
Pooja D, Panyaram S, Kulhari H, Reddy B, Rachamalla SS, Sistla R (2015) Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier. Int J Biol Macromol 80:48–56
Poon W, Zhang YN, Ouyang B, Kingston BR, Wu JLY, Wilhelm S, Chan WCW (2019) Elimination pathways of nanoparticles. ACS Nano 13:5785–5798
Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Qing Max LuG (2011) Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale 3:2801–2818
Pouresmaeil V, Haghighi S, Raeisalsadati AS, Neamati A, Homayouni-Tabrizi M (2021) The anti-breast cancer effects of green-synthesized zinc oxide nanoparticles using carob extracts. Anticancer Agents Med Chem 21:316–326
Prakash S, Malhotra M, Shao W, Tomaro-Duchesneau C, Abbasi S (2011) Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv Drug Deliv Rev 63:1340–1351
Pramanik N, De T, Sharma P, Alakesh A, Jagirdar SK, Rangarajan A, Jhunjhunwala S (2022) Surface-coated cerium nanoparticles to improve chemotherapeutic delivery to tumor cells. ACS Omega 7:31651–31657
Pugazhendhi A, Edison T, Karuppusamy I, Kathirvel B (2018) Inorganic nanoparticles: a potential cancer therapy for human welfare. Int J Pharm 539:104–111
Puvanakrishnan P, Park J, Chatterjee D, Krishnan S, Tunnell JW (2012) In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy. Int J Nanomed 7:1251–1258
Quan Z, Wang X, Li P, Nguyen KT, Wang X-J, Luo Z, Zhang H, Tan NS, Zhao Y (2014) Cancer treatment: biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer-targeted drug delivery in vivo. Adv Funct Mater 24:2413–2413
Rafique M, Sadaf I, Rafique MS, Tahir MB (2017) A review on green synthesis of silver nanoparticles and their applications. Artif Cells Nanomed Biotechnol 45:1272–1291
Rafique M, Sohaib M, Tahir R, Bilal Tahir M, Rizwan M (2021) Plant-mediated green synthesis of zinc oxide nanoparticles using peel extract of citrus reticulate for boosting seed germination of brassica nigra seeds. J Nanosci Nanotechnol 21:3573–3579
Rasmussen JW, Martinez E, Louka P, Wingett DG (2010) Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 7:1063–1077
Razzazan A, Atyabi F, Kazemi B, Dinarvand R (2016) In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes. Mater Sci Eng C 62:614–625
Ruan S, Yuan M, Zhang L, Hu G, Chen J, Cun X, Zhang Q, Yang Y, He Q, Gao H (2015) Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials 37:425–435
Ruan S, Hu C, Tang X, Cun X, Xiao W, Shi K, He Q, Gao H (2016) Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation. ACS Nano 10:10086–10098
Sadhukha T, Wiedmann TS, Panyam J (2013) Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 34:5163–5171
Sadhukhan P, Kundu M, Chatterjee S, Ghosh N, Manna P, Das J, Sil PC (2019) Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy. Mater Sci Eng C 100:129–140
Saikatendu Deb R, Krishna Chandra D, Siddhartha Sankar D (2021) Conventional to green synthesis of magnetic iron oxide nanoparticles; its application as catalyst, photocatalyst and toxicity: a short review. Inorg Chem Commun 134:109050
Salimi M, Sarkar S, Hashemi M, Saber R (2020) Treatment of breast cancer-bearing BALB/c mice with magnetic hyperthermia using dendrimer functionalized iron-oxide nanoparticles. Nanomaterials 10:2310
Sanginario A, Miccoli B, Demarchi D (2017) Carbon nanotubes as an effective opportunity for cancer diagnosis and treatment. Biosensors 7:9
Saroj S, Rajput SJ (2018) Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution. Artif Cells Nanomed Biotechnol 46:S1115–S1130
Schmitt M, Greten FR (2021) The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol 21:653–667
Shan X, Gong X, Li J, Wen J, Li Y, Zhang Z (2022) Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharm Sin B 12:3028–3048
Sharma JR, Sibuyi NRS, Fadaka AO, Meyer S, Madiehe AM, Katti K, Meyer M (2023) Anticancer and drug-sensitizing activities of gold nanoparticles synthesized from cyclopia genistoides (honeybush) extracts. Appl Sci 13:3973
Shetty A, Chandra S (2020) Inorganic hybrid nanoparticles in cancer theranostics: understanding their combinations for better clinical translation. Mater Today Chem 18:100381
Shimasaki Y, Kitahara M, Shoji M, Shimojima A, Wada H, Kuroda K (2018) Preparation of ordered mesoporous Au using double gyroid mesoporous silica KIT-6 via a seed-mediated growth process. Chem Asian J 13:3935–3941
Shukla S, Jadaun A, Arora V, Sinha RK, Biyani N, Jain VK (2015) In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles. Toxicol Rep 2:27–39
Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA: Cancer J Clin 72:7–33
Singh RP, Sharma G, Sonali SS, Kumar M, Pandey BL, Koch B, Muthu MS (2016) Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment. Colloids Surf B 141:429–442
Singh KR, Nayak V, Sarkar T, Singh RP (2020) Cerium oxide nanoparticles: properties, biosynthesis and biomedical application. RSC Adv 10:27194–27214
Singhai NJ, Maheshwari R, Ramteke S (2020) CD44 receptor targeted ‘smart’ multi-walled carbon nanotubes for synergistic therapy of triple-negative breast cancer. Colloids Interface Sci Commun 35:100235
Sokolova V, Epple M (2008) Inorganic nanoparticles as carriers of nucleic acids into cells. Angew Chem Int Ed 47:1382–1395
Song T, Qu Y, Ren Z, Yu S, Sun M, Yu X, Yu X (2021) Synthesis and characterization of polyvinylpyrrolidone-modified ZnO quantum dots and their in vitro photodynamic tumor suppressive action. Int J Mol Sci 22:8106
Sonia I, Ahmad Reza B, Amir MMM (2021) Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy. Coord Chem Rev 442:213949
Soumya M, Rajeshkumar S, Venkat Kumar S (2017) A review on biogenic synthesis of gold nanoparticles, characterization, and its applications. Resour-Effic Technol 3:516–527
Sperling RA, Parak WJ (2010) Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci 368:1333–1383
Strojny B, Grodzik M, Sawosz E, Winnicka A, Kurantowicz N, Jaworski S, Kutwin M, Urbańska K, Hotowy A, Wierzbicki M, Chwalibog A (2016) Diamond nanoparticles modify curcumin activity: in vitro studies on cancer and normal cells and in ovo studies on chicken embryo model. PLoS ONE 11:e0164637
Sulthana S, Banerjee T, Kallu J, Vuppala SR, Heckert B, Naz S, Shelby T, Yambem O, Santra S (2017) Combination therapy of NSCLC using Hsp90 inhibitor and doxorubicin carrying functional nanoceria. Mol Pharm 14:875–884
Sun IC, Na JH, Jeong SY, Kim DE, Kwon IC, Choi K, Ahn CH, Kim K (2014a) Biocompatible glycol chitosan-coated gold nanoparticles for tumor-targeting CT imaging. Pharm Res 31:1418–1425
Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y (2014b) Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed 53:12320–12364
Sweta G, Ashish G, Nitendra KS, Awesh KY (2019) Synthesis and characterization of nanodiamond-anticancer drug conjugates for tumor targeting. Diam Relat Mater 94:172–185
Taghdisi SM, Danesh NM, Lavaee P, Emrani AS, Hassanabad KY, Ramezani M, Abnous K (2016) Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles. Mater Sci Eng C 61:753–761
Tai JT, Lai CS, Ho HC, Yeh YS, Wang HF, Ho RM, Tsai DH (2014) Protein-silver nanoparticle interactions to colloidal stability in acidic environments. Langmuir 30:12755–12764
Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N, Huang C, Shen Z (2022) Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. J Hematol Oncol 15:132
Tjo K, Varamini P (2022) Nanodiamonds and their potential applications in breast cancer therapy: a narrative review. Drug Deliv Transl Res 12:1017–1028
Tsai LC, Hsieh HY, Lu KY, Wang SY, Mi FL (2016) EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment. Nanomedicine 11:9–30
Tummala S, Kumar MN, Pindiprolu SK (2016) Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles. Drug Deliv 23:3505–3519
Urata C, Yamauchi Y, Aoyama Y, Imasu J, Todoroki S, Sakka Y, Inoue S, Kuroda K (2008) Fabrication of hierarchically porous spherical particles by assembling mesoporous silica nanoparticles via spray drying. J Nanosci Nanotechnol 8:3101–3105
Van Der Laan K, Hasani M, Zheng T, Schirhagl R (2018) Nanodiamonds for in vivo applications. Small 14:e1703838
Vassie JA, Whitelock JM, Lord MS (2018) Targeted delivery and redox activity of folic acid-functionalized nanoceria in tumor cells. Mol Pharm 15:994–1004
Vinardell MP, Mitjans M (2015) Antitumor activities of metal oxide nanoparticles. Nanomaterials 5:1004–1021
Wang F, Li C, Cheng J, Yuan Z (2016) Recent advances on inorganic nanoparticle-based cancer therapeutic agents. Int J Environ Res Public Health 13:1182
Wang J, Gao S, Wang S, Xu Z, Wei L (2018) Zinc oxide nanoparticles induce toxicity in CAL 27 oral cancer cell lines by activating PINK1/Parkin-mediated mitophagy. Int J Nanomed 13:3441–3450
Wei L, Lu J, Xu H, Patel A, Chen ZS, Chen G (2015) Silver nanoparticles: synthesis, properties, and therapeutic applications. Drug Discov Today 20:595–601
Wiesmann N, Kluenker M, Demuth P, Brenner W, Tremel W, Brieger J (2019) Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agent. J Trace Elem Med Biol 51:226–234
Wong BS, Yoong SL, Jagusiak A, Panczyk T, Ho HK, Ang WH, Pastorin G (2013) Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev 65:1964–2015
Wu H, Zhang J (2018) Chitosan-based zinc oxide nanoparticle for enhanced anticancer effect in cervical cancer: a physicochemical and biological perspective. Saudi Pharm J 26:205–210
Xiao J, Duan X, Yin Q, Zhang Z, Yu H, Li Y (2013) Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer. Biomaterials 34:9648–9656
Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X, Chen X (2010) PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31:3016–3022
Xie X, Li F, Zhang H, Lu Y, Lian S, Lin H, Gao Y, Jia L (2016) EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Eur J Pharm Sci 83:28–35
Xie M, Deng T, Li J, Shen H (2021) The camouflage of graphene oxide by red blood cell membrane with high dispersibility for cancer chemotherapy. J Colloid Interface Sci 591:290–299
Xu ZP, Zeng QH, Lu GQ, Yu AB (2006) Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 61:1027–1040
Xu C, Shi S, Feng L, Chen F, Graves SA, Ehlerding EB, Goel S, Sun H, England CG, Nickles RJ, Liu Z, Wang T, Cai W (2016) Long circulating reduced graphene oxide–iron oxide nanoparticles for efficient tumor targeting and multimodality imaging. Nanoscale 8:12683–12692
Xu K, Cheng Y, Yan J, Feng Y, Zheng R, Wu X, Wang Y, Song P, Zhang H (2019) Polydopamine and ammonium bicarbonate coated and doxorubicin loaded hollow cerium oxide nanoparticles for synergistic tumor therapy. Nano Res 12:2947–2953
Xuan M, Shao J, Dai L, Li J, He Q (2016) Macrophage cell membrane camouflaged au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces 8:9610–9618
Yang X, Zhang X, Liu Z, Ma Y, Huang Y, Chen Y (2008) High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 112:17554–17558
Yang K, Feng L, Shi X, Liu Z (2013) Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev 42:530–547
Yang G, Phua SZF, Bindra AK, Zhao Y (2019) Degradability and clearance of inorganic nanoparticles for biomedical applications. Adv Mater 31:e1805730
Yang HY, Li Y, Lee DS (2020) Recent advances of pH-induced charge-convertible polymer-mediated inorganic nanoparticles for biomedical applications. Macromol Rapid Commun 41:e2000106
Yang R, Wu R, Mei J, Hu FR, Lei CJ (2021) Zinc oxide nanoparticles promotes liver cancer cell apoptosis through inducing autophagy and promoting p53. Eur Rev Med Pharmacol Sci 25:1557–1563
Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, Dai Z, Zhang X, Zhang L, Peng Y, Ye W, Zeng W, Liu Z, Cheng Q (2022) Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer 21:39
Yoon JH, Cho HJ, Jin HE, Maeng HJ (2019) Mitoxantrone-loaded PEGylated gold nanocomplexes for cancer therapy. J Nanosci Nanotechnol 19:687–690
You Y, Wang N, He L, Shi C, Zhang D, Liu Y, Luo L, Chen T (2019) Designing dual-functionalized carbon nanotubes with high blood-brain-barrier permeability for precise orthotopic glioma therapy. Dalton Trans 48:1569–1573
Yu B, Tan L, Zheng R, Tan H, Zheng L (2016) Targeted delivery and controlled release of Paclitaxel for the treatment of lung cancer using single-walled carbon nanotubes. Mater Sci Eng C 68:579–584
Yuan YG, Peng QL, Gurunathan S (2017) Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment. Int J Nanomed 12:6487–6502
Zarschler K, Rocks L, Licciardello N, Boselli L, Polo E, Garcia KP, De Cola L, Stephan H, Dawson KA (2016) Ultrasmall inorganic nanoparticles: state-of-the-art and perspectives for biomedical applications. Nanomedicine 12:1663–1701
Zavareh HS, Pourmadadi M, Moradi A, Yazdian F, Omidi M (2020) Chitosan/carbon quantum dot/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil. Int J Biol Macromol 165:1422–1430
Zeb A, Rana I, Choi HI, Lee CH, Baek SW, Lim CW, Khan N, Arif ST, Sahar NU, Alvi AM, Shah FA, Din FU, Bae ON, Park JS, Kim JK (2020) Potential and applications of nanocarriers for efficient delivery of biopharmaceuticals. Pharmaceutics 12:1184
Zeb A, Gul M, Nguyen T-T-L, Maeng H-J (2022) Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research. J Pharm Investig 52:683–724
Zhang Q, Neoh KG, Xu L, Lu S, Kang ET, Mahendran R, Chiong E (2014a) Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy. Langmuir 30:6151–6161
Zhang Q, Wang X, Li P-Z, Nguyen KT, Wang X-J, Luo Z, Zhang H, Tan NS, Zhao Y (2014b) Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer-targeted drug delivery in vivo. Adv Funct Mater 24:2450–2461
Zhang Z, Niu B, Chen J, He X, Bao X, Zhu J, Yu H, Li Y (2014c) The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer. Biomaterials 35:4565–4572
Zhang Y, Wu X, Hou C, Shang K, Yang K, Tian Z, Pei Z, Qu Y, Pei Y (2018) Dual-responsive dithio-polydopamine coated porous CeO(2) nanorods for targeted and synergistic drug delivery. Int J Nanomed 13:2161–2173
Zhang H, Li Y, Pan Z, Chen Y, Fan Z, Tian H, Zhou S, Zhang Y, Shang J, Jiang B, Wang F, Luo F, Hou Z (2019a) Multifunctional nanosystem based on graphene oxide for synergistic multistage tumor-targeting and combined chemo-photothermal therapy. Mol Pharm 16:1982–1998
Zhang J, Wang L, You X, Xian T, Wu J, Pang J (2019b) Nanoparticle therapy for prostate cancer: overview and perspectives. Curr Top Med Chem 19:57–73
Zhang X, Song H, Canup BSB, Xiao B (2020a) Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer. Expert Opin Drug Deliv 17:781–790
Zhang Y, Tan J, Zhou L, Shan X, Liu J, Ma Y (2020b) Synthesis and application of AS1411-functionalized gold nanoparticles for targeted therapy of gastric cancer. ACS Omega 5:31227–31233
Zhao R, Li T, Zheng G, Jiang K, Fan L, Shao J (2017) Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex. Biomaterials 143:1–16
Zhao J, Lu M, Lai H, Lu H, Lalevée J, Barner-Kowollik C, Stenzel MH, Xiao P (2018a) Delivery of amonafide from fructose-coated nanodiamonds by oxime ligation for the treatment of human breast cancer. Biomacromol 19:481–489
Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H (2018b) TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Mater Sci Eng C 84:108–117
Zhi F, Dong H, Jia X, Guo W, Lu H, Yang Y, Ju H, Zhang X, Hu Y (2013) Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro. PLoS ONE 8:e60034
Zhifen C, Yu Z, Jichao Z, Huating K, Xiaoxing T, Liang P, Kai X, Ali A, Aiguo L, Renzhong T, Chunhai F, Ying Z (2016) Sodium alginate-functionalized nanodiamonds as sustained chemotherapeutic drug-release vectors. Carbon 97:78–86
Zhou F, Wu S, Wu B, Chen WR, Xing D (2011) Mitochondria-targeting single-walled carbon nanotubes for cancer photothermal therapy. Small 7:2727–2735
Zou Z, He X, He D, Wang K, Qing Z, Yang X, Wen L, Xiong J, Li L, Cai L (2015) Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release. Biomaterials 58:35–45
Acknowledgements
This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2021R1F1A1060378), and the Ministry of Education (NRF-2020R1A6A1A03043708).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors (A. Zeb, M. Gul, T.‑T.‑L. Nguyen, and H.‑J. Maeng) declare that they have no conflict of interest.
Research involving human and animal rights
This article does not contain any studies with human and animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zeb, A., Gul, M., Nguyen, TTL. et al. Recent progress and drug delivery applications of surface-functionalized inorganic nanoparticles in cancer therapy. J. Pharm. Investig. 53, 743–779 (2023). https://doi.org/10.1007/s40005-023-00632-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-023-00632-z